Certificate of Analysis
HEMP QUALITY ASSURANCE TEST

Sample Name:

Site 2 Dwarf

CBD, Hemp Flower

Date Issued:

09/20/2019

Total THC 0.2723%
Total CBD 5.8222%
Sum Cannabinoids 6.757%
Total Cannabinoids 6.7220%

Sample Information

Sample Details

Sample ID:190917N015

Batch Number:Bullseyes Investment

Cultivator / Manufacturer

Show Details

Distributor / Tested For

Show Details

Share

Easily share a link to this results page with your friends, followers, or business partners.

Cannabinoid Analysis - Summary

Total THC: 0.2723%

Total CBD: 5.8222%

Sum of Cannabinoids: 6.757%

Total Cannabinoids: 6.7220%

Total THC/CBD is calculated using the following formulas to take into account the loss of a carboxyl group during the decarboxylation step:
Total THC = Δ9-THC + (THCa (0.877))
Total CBD = CBD + (CBDa (0.877))

Sum of Cannabinoids = Δ9-THC + THCa + CBD + CBDa + CBG + CBGa + THCV + THCVa + CBC + CBCa + CBDV + CBDVa + Δ8-THC + CBL + CBN

Total Cannabinoids = (Δ9-THC+0.877*THCa) + (CBD+0.877*CBDa) + (CBG+0.877*CBGa) + (THCV+0.877*THCVa) + (CBC+0.877*CBCa) + (CBDV+0.877*CBDVa) + Δ8-THC + CBL + CBN

Sum of Cannabinoids: The concentration of each individual cannabinoid added together as they are, without accounting for decarboxylation. This measurement is of particular importance for certain cannabis products that are not intended to be heated prior to application or consumption.

Total Cannabinoids: The concentration of each acidic cannabinoid, multiplied by 0.877 to account for the loss of molecular mass that happens as it is converted to a neutral cannabinoid when heated. Then this calculated concentration is added to the concentrations of the corresponding neutral cannabinoid already present. This corrected data is of particular importance to both producers and consumers of products intended to be heated prior to application or consumption.

View Complete Test Results:

Tested by high-performance liquid chromatography with diode-array detection (HPLC-DAD).

Method: QSP 1157 - Analysis of Cannabinoids by HPLC-DAD

Summary

Total THC: 0.2723%

9-THC+0.877*THCa)

Total CBD: 5.8222%

(CBD+0.877*CBDa)

Total Cannabinoids: 6.7220%

Total CBG: 0.3538%

Total CBG (CBG+0.877*CBGa)

Total THCV: ND

Total THCV (THCV+0.877*THCVa)

Total CBC: 0.2234%

Total CBC (CBC+0.877*CBCa)

Total CBDV: 0.0503%

Total CBDV (CBDV+0.877*CBDVa)

Learn more

The cannabis plant contains dozens of active compounds called cannabinoids. These compounds are the primary contributors to the psychoactive effects of cannabis.

Cannabinoid testing determines the potency of a sample to aid in dosage considerations.

Cannabinoid Test Results

09/20/2019

Result Views

Swipe left on table to see additional columns

Compound LOD/LOQ
(mg/g)
Result
(mg/g)
Result
(%)
Cannabidiol (CBD) 0.059 / 0.180 55.957 5.5957
Cannabigerol (CBG) 0.048 / 0.144 3.310 0.3310
Δ9 Tetrahydrocannabinol (Δ9THC) 0.052 / 0.158 2.723 0.2723
Cannabidiolic Acid (CBDa) 0.052 / 0.156 2.583 0.2583
Cannabichromene (CBC) 0.048 / 0.146 2.234 0.2234
Cannabidivarin (CBDV) 0.027 / 0.080 0.503 0.0503
Cannabigerolic Acid (CBGa) 0.034 / 0.102 0.260 0.0260
Cannabinol (CBN) 0.052 / 0.157 <LOQ <LOQ
∆8 Tetrahydrocannabinol (Δ8THC) 0.074 / 0.224 ND ND
Tetrahydrocannabinolic Acid (THCa) 0.052 / 0.156 ND ND
Tetrahydrocannabivarin (THCV) 0.045 / 0.137 ND ND
Tetrahydrocannabivarinic Acid (THCVa) 0.088 / 0.267 ND ND
Cannabidivarinic Acid (CBDVa) 0.030 / 0.090 ND ND
Cannabicyclol (CBL) 0.114 / 0.346 ND ND
Cannabichromenic Acid (CBCa) 0.233 / 0.705 ND ND
SUM OF CANNABINOIDS 67.570 mg/g 6.757%
Unit Mass:

5 grams

Swipe left on table to see additional columns

Δ9-THC per Unit 13.615 mg/unit
Total THC per Unit 13.615 mg/unit
CBD per Unit 279.785 mg/unit
Total CBD per Unit 291.110 mg/unit
Sum of Cannabinoids per Unit 337.850 mg/unit
Total Cannabinoids per Unit 336.100 mg/unit
Learn more

The cannabis plant contains dozens of active compounds called cannabinoids. These compounds are the primary contributors to the psychoactive effects of cannabis.

Cannabinoid testing determines the potency of a sample to aid in dosage considerations.

Your current browser is unsupported. Please install latest version of Firefox, Chrome or IE to view this site.